Medivolve Inc. · OTC:MEDVF
Medivolve — Investor Presentation (January 2021)
24 slides from Medivolve's investor presentation, Jan 1, 2021
Slide 1: Investor Presentation
INVESTOR PRESENTATION JANUARY 1st, 2021
Slide 2: Disclaimer
DISCLAIMER This presentation of Medivolve Inc. (“Medivolve” or the “Company”) is for informational purposes only and does not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell or issue, or subscribe for any securities of the Company. The informati
Slide 3: Medivolve Investment Overview
OVERVIEW MEDIVOLVE INVESTMENT OVERVIEW Medivolve is a publicly traded company that seeks out disruptive technologies, ground- breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. With a seasoned executive team and renow
Slide 4: COVID-19 Investment Highlights
OVERVIEW COVID-19 INVESTMENT HIGHLIGHTS Medivolve has identified the COVID-19 testing economy as “We’ve gone from 1 million to 4.5 million tests per the most lucrative opportunity: week in the U.S., but we’ll need to redouble our efforts to make it to 30 million tests per week and beyond in Wells Fa
Slide 5: Substantial Upside Per Site
SUBSTANTIAL UPSIDE PER SITE Average Price Per Test: US$95 Estimated Max Tests Per Hour: 15 Highly profitable with Average Hours Per projected EBITDA margins Potential Monthly Day: 10 over 55% Revenue: US$428K 6
Slide 6: Collection Sites - National Footprint
COLLECTION SITES - NATIONAL FOOTPRINT 2021 Rollout: • Operational sites – 32 Sites • Pending Installation: • Phase 1: +13 Sites • Phase 2: +62 Sites • Phase 3: +70 Sites New sites targeting high-population centres 740+ Sites Under Contract 7
Slide 7: Exceptional Leadership
TEAM EXCEPTIONAL LEADERSHIP We make decisions based on world renowned expertise DOUGLAS SOMMERVILLE Dr. GLENN COPELAND Dr. JOSEPH SUGERMAN Dr. LAWRENCE STEINMAN CEO ADVISOR ADVISOR ADVISOR Doug has held prominent roles at Possessing over 45 years of experience Dr. Sugerman is a board-certified Dr. S
Slide 8: Medivolve Investments: Standards & Testing Solutions
MEDIVOLVE INVESTMENTS: STANDARDS & TESTING SOLUTIONS
Slide 9: Restoring Reality Responsibly: Standards
STANDARDS RESTORING REALITY RESPONSIBLY STANDARD FOR SAFE OPERATION: GLENCO MEDICAL CORP. Through Glenco Medical, a 30% owned subsidiary, Medivolve is helping develop and implement a series of protocols for businesses and people to return to normal operation in a COVID-19 environment. These standard
Slide 10: Mining Case Study: Kinross Gold
STANDARDS RESTORING REALITY RESPONSIBLY MINING CASE STUDY: KINROSS GOLD QuestCap has partnered with a subsidiary of Kinross COVID-19 RT-PCR and antibody testing for individuals and staff by trained and certified clinicians. Gold, to provide a comprehensive COVID-19 testing solution for employees at
Slide 11: Sanaty IPS – Clinics & Testing
TESTING SANATY IPS – CLINICS & TESTING Medivolve acquired a 28% indirect equity interest in Sanaty IPS, a government designated health providing institution that provides medical consultation and diagnostic services in Colombia. Sanaty’s currently has two operating clinics in Cucuta and Bogota, in C
Slide 12: Collection Sites COVID-19 Testing Solution
COLLECTION SITES COVID-19 TESTING SOLUTION
Slide 13: Collection Sites at a Glance
COLLECTION SITES COLLECTION SITES AT A GLANCE A complete and versatile solution for the ultra-high demand COVID-19 testing marketing in the U.S. Pop-Up Sites 1 2 3 COVID-19 testing in ultra-high demand Mobile Pop-Up sites Same-day results for 8-10 minute RT- from certified high Potential need for 30
Slide 14: COVID-19 Testing Pricing
COLLECTION SITES COVID-19 TESTING PRICING Stable pricing but very strong need for affordable testing “The American Clinical Laboratory Prices for COVID-19 Diagnostics Tests Association estimates that its members, which have run a collective 11 million (Peterson KFF Health Tracker) coronavirus tests,
Slide 15: Pop-Up Sites Overview
COLLECTION SITES POP-UP sites OVERVIEW Convenient rapid testing centres with certified lab results ▪ Collection Sites Pop-Up sites provides mobile Profile of a Standard Pop-Up Cube and convenient COVID-19 testing with insurance coverage options ✓ Mobile testing sites ▪ 8-10 minutes to administer ant
Slide 16: Nationwide Footprint
COLLECTION SITES NATIONWIDE FOOTPRINT Poised to become the leading affordable Pop-Up sites Footprint COVID-19 testing solution in the U.S. Over 300 Pop-Up sites and counting to be installed across the U.S. in partnerships with major property groups in high-traffic locations 52+ Property Partner Loca
Slide 17: COVID-19 Testing: Antibody, RT-PCR & Antigen
COLLECTION SITES COVID-19 TESTING: ANTIBODY, RT-PCR & ANTIGEN Patients enter the Pop-Up sites and can access three different types of COVID-19 testing: 1 2 3 Rapid Antibody Blood Test RT-PCR Test Antigen Test ▪ Antibody (Serology) tests ▪ RT-PCR tests are real-time reverse ▪ Antigen tests look for p
Slide 18: COVID-19 Testing – How It Works
COLLECTION SITES COVID-19 TESTING – HOW IT WORKS 1 2 3 Rapid Antibody Blood Test RT-PCR Test Antigen Test 1. Samples are collected from the nose or throat of a patient using a swab and are mixed with chemical reagents 2. Samples are put in a machine that duplicates the genetic material and detects i
Slide 19: Strategic Diagnostics Partner: Alcala Labs
COLLECTION SITES STRATEGIC DIAGNOSTICS PARTNER Customized Approach • Determine the needs of an organization and is a fully registered and resources necessary to execute licensed laboratory under the laws Proven Alcala System and requirements of California, Test Collection located in San Diego • Exec
Slide 20: Medivolve Team
MEDIVOLVE TEAM
Slide 21: Strategic Advisors
TEAM STRATEGIC ADVISORS MICHAEL MCCARTHY JIM ROGERS MIKE MANCIAS RICHARD DOLAN Mike is widely recognized across Mr. Rogers co-founded the Mike has served as the Chief Richard is an advocate and Canada as a health care champion Quantum Fund, a global- Performance Advisor to LeBron James researcher on
Slide 22: Directors & Officers
TEAM DIRECTORS & OFFICERS DOUGLAS SOMMERVILLE DANIYAL BAIZAK WEN YE DR. BEVERLEY RICHARDSON DIRECTOR DIRECTOR DIRECTOR CEO, DIRECTOR • Financial and strategic advisor on M&A • CPA, CGA and holds a Bachelor of Commerce • Decades of experience as psychotherapeutic • Experience in Central Asian and deg
Slide 23: Inquiries
INQUIRIES Douglas Sommerville, CEO Contact: Doug.Sommerville@medivolve.ca 24
Slide 24: Disclaimer – Rescission Rights
DISCLAIMER – RECISION RIGHTS In certain circumstances, purchasers resident in certain provinces of Canada are provided with a remedy for rescission or damages, or both, in addition to any other rights they may have at law, where an offering memorandum (such as this presentation) and any amendment to